SCHEMBL30394685

SCHEMBL30394685

C=C(CN1C(=O)CCc2cc(-c3ccc(C(F)(F)F)cc3)ccc21)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.41
MAPT P10636 2/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC1 Q13547 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
HRH3 Q9Y5N1 1/20 0.38
TP53 P04637 1/20 0.38
TDP2 O95551 1/20 0.38
NOTUM Q6P988 1/20 0.38
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ATAD2 Q6PL18 1/20 0.36
DGAT1 O75907 1/20 0.36
SCN9A Q15858 2/20 0.36
MET P08581 1/20 0.36
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3306413 0.88 KIF11 (0.44) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL30393232 0.85 CYP11B1 (0.41) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL3315684 0.85 HDAC6 (0.44) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL3310395 0.85 KIF11 (0.43) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL4596531 0.82 GRIN1 (0.46) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL3311164 0.81 S1PR1 (0.46) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL3306832 0.80 MET (0.47) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL3309660 0.80 KIF11 (0.45) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL3306622 0.80 CYP11B1 (0.46) KIF11MAPTHDAC6HDAC1CYP1A2
SCHEMBL13273166 0.79 CYP11B2 (0.60) KIF11HDAC6HDAC1CYP1A2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023059605-A1 HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE HALDA THERAPEUTICS OPCO, INC. (US) 2023-04-13 WO disclosed